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SUlfur Benzo[a]pyrene (BaP) and sulfur dioxide
gen with .b ....o.a]pyrne(IaP the..s.. (SO2) are common industrial and environ-
..at t....ct.. ental contaminants. Epidemiological evi-
th.. i....c..n ..r...d.y. dence suggests that high levels of SO
r.-9............0 increase the incidence of respiratory tract
~carcinoma in humans (1,2). Further, chron-
pirtor ith lil lA
i
ne We ic concurrent inhalation exposure to SO
~~iis~ [3H and BaP results in an increased incidence of
~upper respiratory tract neoplasia in rats (3)
the: and hamsters (4) over that seen with BaP
alone. These findings suggest that SO is a
analy.TSis cocarcinogen for BaP in the respiratory
al.ai..f.....l tract. We have investigated the chemical,
metabolic, and genotoxic interactions of
so the form of the hydrated sulfite
.derived f"t
anion, with the BaP metabolites (±-trans-
~7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene
(BaP-7,8-diol)(5-7) and (±)-7r,8t-dihy-
droxy-9t, IlOt-epoxy-7,8,9, lO0-tetrahydroben-
zo[a]pyrene (anti-BPDE)(6,8-10). In sub-
ite -derived reactants can
.3 . -7,8-diol to convert it to
t-BPDE (5) and also add to BP-7,8-diol
~ ~ ~ produce a sulfonate derivative (7,11).
and......t.. Sulfite, a potent nucleophile, also efficiently
ie.....d.
eAt eintea acks anti-BPDE to produce 7r,8tt-tri-
hydroxy-7,8,9, 1 0-tetrAhydrobenzo [a]
~Pyrene-I1Oc-sulfonate (BPT-i10-sulfon-
ate)(8). Although it is far more stable than
anti-BPDE, BPT- 10-sulfonate retains the
C. osaip ability to bind covalently to DNA (8).
Sulfite thus not only can increase the forma-
........d of..... tion. of the highly reactive alkylating agent
~anti-BPDE, but it can also produce an addi-
-fona~t6
..fo was. be.o.. tional class of alkylating agents, the BaP
for. ...a triol sulfonates (7,8).
These reactions between sulfite and BaP
Rderivatives also occur in the presence of
~~~viable cells. In bacterial mutagenicity assays
.....e using Salmonella typhimurium strains TA98
un.. le..... and TA100, sulfite activates BaP
as a mutagen ,and strongly potentiates
.d.im cou...f....w..s.an the mutagenicity of anti-BPDE (6,8-10).
The ability of sulfite to enhance the geno-
DNAicity of mutagenic BaP derivatives pro-
vides a plausible mechanism for the ob-
........ served cocarcinogenic effect of SO2 with
BaP (6-) A critical question, however, is
whether these same reactions can occur in
....the more complex milieu of an intact mam.-
malian cell system. We have addressed this
..........question by examining the interactions of
sulfite and anti-BPDE in cultured murine
............. .respiratory epithelial cells. The Balb/c-
derived CIO cell line was chosen as an
appropriate system for these studies. This is
a stable respiratory epithelial cell popula-
tion with characteristics similar to those of
alveolar type II cells (12). We have used
this system to examine both the intracellu-
lar and extracellular chemical interactions
of anti-BPDE and sulfite and to examine
the effects of these interactions on the
uptake and nuclear localization of, and on
the covalent modification of cellular
macromolecules by, anti-BPDE-derived
species. Our findings demonstrate the for-
mation of BPT-10-sulfonate in a viable
mammalian cell system and suggest the
possible significance of this formation in
regard to the modification ofnuclear DNA
and possible mutagenic consequences.
Materials and Methods
Chemicals
Racemic anti-BPDE and randomly labeled
[3H]-anti-BPDE (specific activity, 1430
mCi/mmol) were supplied by the National
Cancer Institute repository and dissolved in
anhydrous silylation grade tetrahydrofuran
(THF). THF and dimethylsulfoxide
(DM50) were purchased from Pierce
Chemical Co. (Rockford, Illinois); 99+%
triethylamnine (TEA) was from Aldrich
Chemical Company (Milwaukee, Wiscon-
sin). All other chemicals and solvents were
purchased from Fisher Scientific (St. Louis,
Missouri) unless otherwise specified.
Hydrolysis ofanti-BPDE to obtain the iso-
meric 7,8,9,10-tetrahydroxy-7,8,9,1I0-
tetrahydrobenzo[a]pyrenes (BaP tetraols)
standards was carried out as described pre-
viously (13). Synthesis and characterization
of BPT-10-sulfonate and [3H]-BPT-10-
sulfonate (specific activity, 57 mCi/mmol)
was accomplished as previously described
(8). We carried out all procedures under
subdued light. Synthetic products were
stored as dry solids under nitrogen at
-20'C. Stock solutions used in incubations
were prepared fresh daily in dry DMSO.
All stock solutions were determined to be
>99% pure by HPLC. Analytical HPLC
was conducted using a 4.6 x 250 mm
Ultrasphere ODS column (Beckman In-
struments Co., Fullerton, California) elut-
ed with a methanol-water gradient (8).
Detection consisted ofmonitoring absorb-
ance (344 nm) and fluorescence (344 nm
excitation, 380 nm emission).
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Cell Cultures
CIO cells, derived from type II respiratory
epithelial cells from Balb/c mice, were pro-
vided by Gary Smith (University of New
South Wales) (12. The cells were grown in
CMRL 1066 (Gibco Inc., Bethesda, MD)
medium containing 100 U/ml penicillin G,
100 pg/ml streptomycin, and 10% fetal
bovine serum, at 370C in an atmosphere of
5 % CO2.
Uptake and Localization ofLabeled
BaP Derivatives
We seeded eight-well cell culture slides
(Nunc Inc., Naperville, Illinois) with 4 X
10 3 cells/well and incubated them as
described above for 24 hr to achieve 80-90
% confluent monolayers. The medium was
replaced by sterile phosphate-buffered saline
(PBS) and [3H]-anti-BPDE, diluted with
unlabeled diol epoxide to a specific activity
of 50 pCi/pmol, or [3H]-BPT-10-sulfonate
(57 liCi/pmol) solutions in DMSO were
added. DMSO concentration was held con-
stant at 1 % (v/v). Where indicated, we
added sterile solutions of sulfite in PBS 3
min before the addition of [3H]-anti-
BPDE. Total volume for all wells was 250
pl. All slides were incubated at 37'C under
5% CO2. After the incubation period, we
removed the PBS for analysis by HPLC and
washed the wells gently three times each
with 250 p1 of 50% aqueous methanol to
remove unbound BaP derivatives. The cells
were fixed for 1 hr in 4% aqueous glu-
taraldehyde, washed with distilled water,
and air dried. The slides were coated with
Kodak NTB-2 liquid photographic emul-
sion and exposed for approximately 28 days
at 0C. After development with Kodak
Dectol developer, the cells were stained with
a hematoxylin:eosin stain. Resolution of
cells and automated grain counts were
accomplished under darkfield illumination
using a Nikon Type 108 Analytical Micro-
scope. Automated data collection was
accomplished using the Image Analysis
System (Analytical Imaging Concepts,
Atlanta, Georgia). We quantitated the
extent ofnuclear localization bymicroscopic
examination (at 1OOOx) and countingdevel-
oped silver grains over the nuclei ofat least
20 randomly selected cells. Background
grain counts were made in areas directly
adjacent to the cells, and the values were
used to correct the counts for the cells.
Results are expressed as the means ± SD for
counts from asinglewell.
Subcellular Localization of[3H]-anti-
BPDE-Derived Products
C10 cells were grown to confluent mono-
layers in CMRL 1066 medium as described
(approximately 3 x 106 cells/I00 mm
plate). The cells were gently washed with
PBS, and an aliquot ofsterile PBS was lay-
ered over the cells. We then added a
DMSO solution of [3H]-anti-BPDE (50
pCi/pmol) then for a final concentration of
1 pM [3H]-anti-BPDE. The DMSO con-
tent ofthe incubations was always 1% (v/v).
Where indicated, aliquots of aqueous sodi-
um sulfite were added 3 min before addi-
tion of [3H]-anti-BPDE to give a final sul-
fite concentration of 1 or 10 mM. The final
volume of PBS and additions was 3.0 ml.
The cells were then incubated at 370C in an
atmosphere of 5% C02/95 % room air. At
the conclusion of each incubation, we
removed PBS and analyzed for metabolite
content by HPLC. Cells from three repli-
cate plates were washed with PBS, harvest-
ed, pooled, and resuspended in 50 ml of
PBS.
We isolated nuclei from this cell suspen-
sion following the method of Schildkraut
and Maio (14). Briefly, the cells were pellet-
ed by centrifugation at 15OOg for 20 min,
resuspended in 25 ml of 0.01 M Tris, pH
7.4 containing 0.3 mM CaCl2 and 0.5%
Triton X-100, and incubated at 0C for 10
min. The cells were then disrupted using a
Potter-Elvejhem homogenizer. Light mi-
croscopy of this homogenate revealed that
greater than 85% ofthe cells were lysed. We
centrifuged the homogenates at 300gfor 10
min, and the resulting cytosolic fraction was
removed for analysis oftotal radioactivity by
liquid scintillation counting, protein content
(15), and covalent binding (16), and anti-
BPDE metabolite content (8). The crude
nuclear pellet was resuspended in 8.75 ml of
2.0 M sucrose containing 1.5 mM CaCI2
and buffered with 0.01 M Tris, pH 7.4, and
then layered onto a 5.25 ml cushion of 2.2
M sucrose in an ultracentrifuge tube. This
sample was centrifuged at 50,000 gfor 1 hr.
The supernatant was discarded and the pel-
let resuspended in 1.0 ml PBS. We assessed
purity of the nuclear preparation using
phase-contrast microscopy. Aliquots (100 pil)
of the nuclear fraction were assessed for
radioactivity, metabolite content, and pro-
tein binding as described above. The re-
mainder ofthe nuclear fraction was retained
for DNA isolation. DNA was isolated by
phenol-chloroform extraction, RNAse A
treatment, and ethanol precipitation. The
purified DNA was lyophilized and redis-
solved in 10 mM NaCl-1 mM EDTA,
quantitated by absorbance at 260 nm (20
AU/mg DNA/ml), and the bound labeled
material was then quantitated by liquid scin-
tillation counting. All incubations were run
in triplicate, and results are reported as
means ± SDs.
Results and Discussion
Effects ofSulfite onthe Cellular
Localization of[3H]-antiBPDE
The effect ofsulfite on the cytoplasmic and
nuclear localization of [3H]-anti-BPDE in
CI0 cells was first examined by autoradi-
ographic methods. Results were quantified
by automated image analysis and data col-
lection of exposed silver grains associated
with nuclei. Initial studies examined the
concentration dependence for this nuclear
localization and its enhancement by sulfite.
In cells exposed for 4 hr to [3H]-anti-
BPDE alone, a concentration-dependent
increase in nuclear localization was noted
over the concentration range of 0.05-1.0
pM (Fig. 1). Upon inclusion of 1 or 10
mM sulfite, there was an increase of up to
86% in the level of nuclear localization of
[3H]-anti-BPDE-derived material at all
concentrations of [3H]-anti-BPDE over
that seen in the absence of sulfite (Fig. 1).
The extent of enhancement of anti-BPDE
localization elicited by 1 and 10 mM sulfite
was identical. The diol epoxide is readily
able to partition across membranes to reach
all cellular compartments. The increased
nuclear localization relative to other or-
ganelles may well result from the noted
specificity for covalent binding to double-
stranded DNA exhibited by anti-BPDE
(16). Clearly, a substantial increase in
nucleus-associated label resulted from this
treatment with sulfite. We have reported
previously that sulfite increased the cova-
lent modification of DNA by anti-BPDE
and the resultant genotoxicity in bacterial
systems (9), and the data shown here sup-
port a similar interaction in a mammalian
cell system.
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Figure 1. Effect of sulfite on the nuclear localiza-
tion of 13H]-anti-BPDE-derived products. C10 cells
were incubated for 4 hr at 370C with [3H]-anti-
BPDE and sulfite. The cells were fixed and dried,
and autoradiograms were prepared as described
in Materials and Methods. Following develop-
ment, the cells were stained with hematoxylin-
eosin, and the extent of nuclear localization was
visualized by microscopic examination. The
extent of nuclear localization was quantitated by
microscopic examination (at lOOOx) and counting
developed silver grains over the nuclei of at least
20 randomly selected cells. Background grain
counts were made in areas directly adjacent to
the cells, and the values were used to correctthe
counts for the cells. Data are expressed as the
means ± SDs of all corrected nuclear counts.
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We examined the kinetics of anti-BPDE
uptake and the effects of sulfite on this
process using 0.1 pM for the diol epoxide
and 1 mM for sulfite. The concentration
of diol epoxide was chosen based both on
the potent stimulation of nuclear localiza-
tion due to sulfite at that concentration
(Fig. 1) and on the position of this diol
epoxide concentration within the reported
dose-response range for mutagenicity in
mammalian cell systems (17-19). We
chose the sulfite concentration based on
the equal effects of 1 and 10 mM sulfite
observed at the 4-hr time point (Fig. 1)
and on our previous experience with sulfite
and anti-BPDE in bacterial test systems
(6,8-10). The half-life of anti-BPDE in
aqueous systems is about 2 min (18), indi-
cating that uptake, distribution, and cova-
lent binding ofthe diol epoxide must take
place rapidly. The products of these reac-
tions will then be either retained within
the cell or eliminated, depending on the
relative polarity ofthe products. In control
incubations exposed only to anti-BPDE,
there was an initial burst of nuclear local-
ization during the first 15 min of incuba-
tion, with a more gradual increase between
15 and 60 min (Fig. 2). Between 60 and
240 min, only a 44% increase in nuclear
labeling was observed. The net nuclear
localization ofdiol epoxide-derived materi-
als in the presence of 1 mM sulfite was
indistinguishable from the extent of net
localization observed with the diol epoxide
alone during the first 60 min of incuba-
tion. A distinct enhancement of nuclear
localization was elicited by sulfite at the
later time points: the labeling ofnuclei was
increased by 31% at 120 min and by 88%
C,
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Figure 2. Sulfite and the kinetics of nuclear local-
ization of [3H1-anti-BPE-derived products. C10
cells were exposed to 0.1 pM [3H -anti-BDE (50
pCi/pmol) in the presence of 0 or 1 mnM sulfite.
Incubations were stopped after 3, 7, 15, 30, 60,
120, and 240 min. The cells were then washed,
fixed, and analyzed by autoradiography as de-
scribed in Materials and Methods and in Figure 1.
at 240 min relative to the levels observed
in the absence of sulfite. Although these
data do not rule out effects of sulfite on
cellular components leading to this in-
creased nuclear localization, our findings
also are consistent with the formation ofa
more stable species than anti-BPDE, which
possesses reactivity or structural features
that favor its accumulation in the nucleus
and inhibit its release into the extracellular
environment. Such properties are in agree-
ment with the reported reactivity and
apparent polarity of BPT-10-sulfonate
(8,10).
Effects ofSulfite on the Subcellular
Distribution and Macromolecular
Binding ofanti-BPDE
In regard to genotoxicity, the effects ofsul-
fite on the behavior of anti-BPDE within
the nucleus and resultant covalent binding
to DNA are of great interest. CO0 cells
from incubations similar to those described
above were lysed and fractionated by cen-
trifugation to produce a cytosolic and a
nuclear fraction. Covalent binding of
labeled materials to protein from each of
these fractions was determined, and cova-
lent modification of DNA from the nuc-
lear fraction also was measured. CI0 cells
exposed to 1 pM [3H]-anti-BPDE and
either 1 or 10 mM sulfite showed modest
increases in the levels of cytosolic and
nuclear protein binding of [3H]-anti-
BPDE-derived products over that seen in
the absence ofsulfite (Table 1). Analysis of
the protein binding data by one-way
ANOVA followed by Fisher's least signifi-
cant difference analysis established that the
increase elicited by 10 mM sulfite in both
cytosolic and nuclear protein binding was
statistically significant (p<0.05), but not at
1 mM sulfite. The effects of sulfite on
DNA binding, however, were far more
impressive. When 1 mM sulfite was in-
cluded, resultant DNA modification was
increased by 130%, and 10 mM sulfite
elicited a 210% increase in the level of
DNA binding over that observed with
[3H]-anti-BPDE alone (Table 1). This
increased binding of [3H]-anti-BPDE-
derived products to both the nuclear pro-
tein fraction and DNA demonstrates
effects of sulfite consistent with an en-
hanced genotoxic response.
We analyzed the supernatants from the
cytosolic and nuclear fractions by HPLC
to characterize the stable end products
derived from [3H]-anti-BPDE. Represen-
tative radiochromatograms are shown in
Figure 3. In the absence ofsulfite, both the
cytosolic and the nuclear fractions con-
tained the two diastereomeric BaP tetraols
formed by the spontaneous hydrolysis of
anti-BPDE. No detectable glutathione
conjugates of the diol epoxide were seen
(tR = 14.7 min). Sulfite reduces the scav-
enging efficiency ofthe cellular glutathione
system by depleting reduced glutathione
(9,20) and by inhibiting the enzyme glu-
tathione-S-transferase (20,21). Such inhi-
bition of glutathione-dependent pathways
has been advanced as a possible explana-
tion for the increased mutagenicity and
cytotoxicity of BaP derivatives in cell sys-
tems (20-24). It.is possible that sulfite
inhibits the glutathione-S-transferase sys-
tem in CI0 cells, thus increasing the effec-
tive concentration of anti-BPDE. The lack
of detectable glutathione-BPDE conju-
gates in the subcellular fractions from these
cells or in the extracellular medium (data
not shown) argues against a critical role for
this conjugation pathway. This apparent
diminished role for glutathione-dependent
detoxication of anti-BPDE in C10 cells
does not agree with reports from some
other mammalian cell systems (20,22-24),
but it does agree with our observations in
bacterial systems (8,9). Moreover, mam-
malian cell types are known in which glu-
tathione-dependent pathways are not
important modulators ofdiol epoxide toxi-
city (25).
Analysis of subcellular fractions from
cells treated with either 1 or 10 mM sulfite
demonstrated not only the formation of
BaP tetraols, but also the presence ofBPT-
1O-sulfonate (tR = 10,11 min). The pres-
ence of the BaP tetraols in both cytoplas-
mic and nuclear fractions indicates that the
relatively lipophilic anti-BPDE readily par-
titions into cells and into the nucleus. The
presence of BPT-10-sulfonate in fractions
derived from cells exposed to anti-BPDE
and sulfite indicates either that the forma-
tion ofBPT-10-sulfonate occurs within the
cell or that BPT-10-sulfonate formed in
the extracellular environment is able to
enter intact cells.
Table 1. Protein and DNA binding of anti-BPDE-derived materials
Fraction Sulfite, mM Protein binding, pmol/mg DNA binding, pmol/mg
Cytosolic 0 80±6 ND
1 93± 10 ND
10 108±7 ND
Nuclear 0 76± 6 4.8 1.5
1 86±10 11.1±0.3
10 111 ± 12 14.9±0.6
ND, not determined. Fractions were isolated and protein and DNA binding measured as described in
Materials and Methods. Data representthe means ± SDs oftriplicate determinations.
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Figure 3. HPLC analysis of [3HJ-anti-BPDE-derived products. Supernatants from the cytosolic and nuclear fractions from CIO cells exposed to 1 pM [3H]-anti-
BPDE in the presence of 0, 1, and 10 mM sulfite were analyzed by HPLC, as described in Materials and Methods. Product identity, based on retention time: tR = 3
min, impurity in [3H]-anti-BPDE; (*) 10, 11 min = BPT-10-sulfonates; (**) 20, 23 min = BaP tetraols. The tetraols eluting at 20 and 23 min are known to be the trans-
and cis- diastereomers, respectively. The same relationship is assumed forthe two BPT-10-sulfonates, which elute at 10 and 11 min (8).
Uptake and Nuclear Localization of
[3H]-BPT-10-sulfonate
The site offormation ofBPT-10-sulfonate
and the ability of this BaP derivative to
cross cellular membranes are critical issues
to address in regard to the mechanisms and
significance ofsulfite-diol epoxide interac-
tions. We examined the ability ofBPT-10-
sulfonate to cross cellular membranes by
exposing C10 cells to [3H]-BPT-10-sul-
fonate over an extracellular concentration
range of 1-20 pM. Autoradiograms, pre-
pared and analyzed as described above,
demonstrated that for concentrations of
1-10 pM BPT-10-sulfonate, there was no
significant nuclear localization of labeled
materials (Fig. 4). At a concentration of20
pM BPT-10-sulfonate, a fourfold increase
above background was noted in the num-
ber of grains/nucleus. This apparent
nuclear localization is less than 7% of the
nuclear localization observed with anti-
BPDE alone (Fig. 1), and about 4% ofthe
level obtained with anti-BPDE in the pres-
ence ofsulfite (Fig. 1), despite the fact that
the BPT-10-sulfonate concentration was
80-fold higher than the anti-BPDE con-
centration chosen for this comparison.
This result is consistent with the inability
of BPT-10-sulfonate to partition into
octanol from an aqueous milieu (Green JL,
unpublished observations), as well as our
previously reported findings regarding the
bacterial mutagenicity ofthese compounds
(7-9). BPT-10-sulfonate simply cannot
enter intact cells, whereas anti-BPDE and
sulfite do enter cells efficiently. This inabil-
ity of BPT-10-sulfonate to cross mem-
branes supports two critical corollaries
relating to the disposition of BaP deriva-
tives in the presence of sulfite. The first is
that any BPT-10-sulfonate found in intra-
cellular fractions, such as the cytosolic and
I
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Figure 4. Nuclear localization of [3HJ-BPT-10-sul-
fonate. C10 cells were treated with 1 to 20 pM
13H1-BPT-10-sulfonate for 4 hr and analyzed as
described in Figures 1 and 2. Data are expressed
as the means ± SDs.
nuclear fractions examined here, must
result from the intracellular reaction
between sulfite and anti-BPDE. Second, if
BPT-10-sulfonate is formed within a cell,
it very likely cannot be excreted from that
cell.
In summary, C10 murine respiratory
epithelial cells exposed to anti-BPDE and
sulfite show enhanced nuclear localization
of anti-BPDE-derived material. Results
from examination ofthe time course of net
nuclear localization ofdiol epoxide-derived
species indicate that sulfite does not alter
this process detectably during the first
hour, but rather that it extends the linear
increase in net localization between 1 and
4 hr. The presence ofsulfite increased the
covalent modification of DNA by diol
epoxide-derived species up to threefold.
Detection ofBPT-10-sulfonate in cytosolic
and nuclear fractions derived from cells
exposed to both anti-BPDE and sulfite
demonstrates the presence of another
potentially reactive species in addition to
the highly reactive epoxide. The inability
of [3H]-BPT-10-sulfonate to partition
across membranes may indicate that it is
unable to be eliminated from the cell,
thereby increasing the exposure to a more
stable reactive intermediate than anti-
BPDE. The net effect ofthis sequestration
is the enhanced exposure ofcritical cellular
Volume 102, Number2, February 1994
a. s L 500-
0 -
1000
Nuclear
0 mM 503
-
U
219mu.
targets to a longer-lived reactive intermedi-
ate that is capable ofbinding to DNA.
These data support the ability ofsulfite
to increase the level of [3H]-anti-BPDE-
derived product localized within the nucle-
us of exposed cells. Unfortunately, the
binding levels and autoradiographic studies
do not distinguish the individual contribu-
tions toward binding made by anti-BPDE
and BPT-10-sulfonate. Detailed character-
ization of the structures of DNA adducts
formed by BPT-10-sulfonate and on the
sequence specificity for their formation are
underway. If specific marker adducts or a
pronounced sequence specificity is found
for BPT-10-sulfonate that distinguish it
from anti-BPDE, then the tools will be in
hand to conclusively assess the toxicologi-
cal significance ofthis novel derivative.
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